sb 202190 has been researched along with Psoriasis in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funding, AT | 1 |
| Johansen, C | 1 |
| Kragballe, K | 1 |
| Otkjaer, K | 1 |
| Jensen, UB | 1 |
| Madsen, MW | 1 |
| Fjording, MS | 1 |
| Finnemann, J | 1 |
| Skak-Nielsen, T | 1 |
| Paludan, SR | 1 |
| Iversen, L | 1 |
1 other study available for sb 202190 and Psoriasis
| Article | Year |
|---|---|
Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines.
Topics: Adult; Anisomycin; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cytokines; DNA-Bind | 2006 |